FDA-approved and made in the USA- Heart-health benefits beyond weight-loss*
- Clinician guided dosing
1
2
3
4
Are you looking for weight loss medication?
(That’s the only kind we have)
Yes, please
I am not sure
Good News!
We have the meds that you want.
- FDA-approved and made in the USA
- Heart-health benefits beyond weight-loss*
- Clinician guided dosing
Get started
Read our TrustPilot reviews
Read our App Store reviews
FuturHealth’s Website Certification Status on LegitScript
Side effects of Wegovy® may include possible thyroid tumors. See here for details.
*In a multi-national, double-blind clinical trial of over 17,000 patients with BMI of 27 or greater, weekly injections of semaglutide for a mean duration of 33 months reduced the risk of a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke by 20%. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563.
Read our App Store reviews
FuturHealth’s Website Certification Status on LegitScript
Side effects of Wegovy® may include possible thyroid tumors. See here for details.
*In a multi-national, double-blind clinical trial of over 17,000 patients with BMI of 27 or greater, weekly injections of semaglutide for a mean duration of 33 months reduced the risk of a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke by 20%. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563.